Business
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
75% of patients who die from colorectal cancer (CRC) are not screened, often because traditional options are viewed as unpleasant or inconvenient Guardant’s
About this update from Guardant Health, Inc.
[{"type":"text","content":"\n\n75% of patients who die from colorectal cancer (CRC) are not screened, often because traditional options are viewed as unpleasant or inconvenient\n\n\n\nGuardant’s FDA-approved Shield offers screening with a simple blood draw from any prescribing healthcare provider for adults 45+ at average risk for CRC\n\n\n\nAfter a CRC diagnosis, Van Der Beek is speaking up for the first time to advocate to get more people screened\n\n\n\n PALO ALTO, Calif.--(BUSINESS WIRE)--\nGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its partnership with actor and health advocate James Van Der Beek to increase awareness about colorectal cancer (CRC) screening and the Shield™ blood test. Approved by the U.S. Food and Drug Administration (FDA) last year, Shield offers a convenient and more pleasant new option for CRC screening for eligible individuals 45+.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728751799/en/\nKnown for iconic roles in Varsity Blues, Rules of Attraction and Don’t Trust the B in Apartment 23, Van Der Beek has created many memorable characters in his 20+-year TV and film career, both on screen and as a producer, director and writer. Van Der Beek went public with his CRC diagnosis in November 2024 to encourage others to take control of their health. Today marks the first time he is speaking out about the critical importance of staying up to date with CRC screening guidelines.\n\n\n“I was 46 years old, in great physical shape, and had no idea I was living with stage 3 colorectal cancer. It’s the second most deadly cancer, but the most curable when caught in its early stages, making screening crucial,” said Van Der Beek. “I was relieved to learn about Guardant’s Shield blood test because it’s a more pleasant and convenient way to get screened, especially for those who’ve been hesitating. I’ve learned a lot on my cancer journey, but I wouldn’t wish this on anyone. Simply put, getting screened can save your life. If you’re 45 or older, make sure you talk to your doctor about screening guidelines and your options.”\n\n\nCRC is a significant health concern with over 50,000 Americans dying from the disease each year, making it the second most deadly cancer in the U.S. Early detection is crucial, as the five-year survival rate i...